# Characterization of Hospitalized Patients With Dengue Fever in Can Tho City: A Cross‐Sectional Analysis, 2018‐2019

**Authors:** Thuy Thi Thu Nguyen, Phuong Vu Mai Hoang, Hang Le Khanh Nguyen, Hau Thi Bich Vu, Phuc Van Tran, Truc Minh Huynh, Hung Minh Ha, Thanh Huy Ong, K. Morita, F. Hasebe, Mai Thi Quynh Le

PMC · DOI: 10.1155/cjid/6410209 · The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale · 2026-02-25

## TL;DR

This study analyzed hospitalized dengue patients in Can Tho City, Vietnam, to identify factors associated with severe disease and the circulating dengue serotypes.

## Contribution

The study provides insights into dengue serotype distribution and risk factors for severe disease in a vulnerable urban population.

## Key findings

- 88.6% of dengue patients were under 15 years old, with 66.7% experiencing secondary infections.
- DEN-1 was predominant in 2018, while DEN-1 and DEN-2 were primary causes in 2019.
- Warning signs included high fever, rapid pulse, abdominal pain, and bleeding.

## Abstract

Dengue poses a significant public health issue in tropical and subtropical countries, especially in urban areas. Can Tho, the fourth‐largest city in Vietnam’s Mekong Delta, is highly vulnerable to climate change. This study characterizes dengue fever (DF) and identifies factors linked to severe disease in hospitalized patients from 2018 to 2019. We analyzed the clinical manifestations of 123 patients, along with blood count tests, RT‐PCR, the NS1 antigen rapid test, and ELISA for IgM and IgG antibodies, upon admission. The results revealed that 88.6% of dengue patients were under 15 years, primarily treated at Can Tho Pediatric Hospital, with 66.7% experiencing secondary infections. Warning signs included high fever, rapid pulse, abdominal pain (54.4%), nausea/vomiting (43.2%), and bleeding (5.7%). DEN‐1, DEN‐2, and DEN‐4 circulated during the study, with DEN‐1 predominating in 2018 (85.7%) and both DEN‐1 and DEN‐2 as primary causes in 2019 (52.2% and 39.1%, respectively). The DEN‐2 serotype and secondary infections may significantly contribute to severe dengue, and further research on dengue immunity is essential for understanding the effects of dengue vaccination.

## Linked entities

- **Diseases:** dengue fever (MONDO:0005502), dengue (MONDO:0005502)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, IVNS1ABP (influenza virus NS1A binding protein) [NCBI Gene 10625] {aka ARA3, FLARA3, HSPC068, IMD70, KLHL39, ND1}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}
- **Diseases:** deaths (MESH:D003643), dengue secondary infection (MESH:D060085), lethargy (MESH:D053609), Infection (MESH:D007239), nausea or vomiting (MESH:D020250), dengue hemorrhagic fever (MESH:D019595), abdominal pain (MESH:D015746), SD (MESH:D012735), hemorrhagic tendency (MESH:C536965), bleeding (MESH:D006470), DF infection (MESH:D003715), nausea (MESH:D009325), vomiting (MESH:D014839), febrile illness (MESH:D005334)
- **Chemicals:** Qdenga (-), H2O (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Dothidea sp. ENV1 (species) [taxon 154308], Dengue virus group (clade) [taxon 11052]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935753/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935753/full.md

---
Source: https://tomesphere.com/paper/PMC12935753